Replies to post #948 on Revance Therapeutics Inc (RVNC)

[DewDiligence]

AGN can leverage its huge sales force to seed doubt. The reps will just throw the equivalent of FUD to the providers. RVNC will need to partner to have the share of voice necessary to counter that crap.

I don’t fully concur. Compared to most drug classes, botulinum toxin for aesthetic indications produces clearly observable results, so injectors will be able to see through the ‘FUD’ relatively quickly and easily.